Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-03 ,pp. : 1395-1401

Spandidos Publications

Access to resources Recommend Favorite

The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance

By Wroblewski David  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 237-247

Oxford University Press

Access to resources Recommend Favorite

Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: A prospective combination of ABT-737 and TMZ for treating glioma

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1304-1316

Spandidos Publications

Access to resources Recommend Favorite

Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy

By Larkin James   Porter Colin  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 60-69

Springer Publishing Company

Access to resources Recommend Favorite

Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model

By                    

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 667-672

Spandidos Publications

Access to resources Recommend Favorite